Robert Kelly is managing director of XTS Energy LLC, and has more than three decades of experience as a business executive. He is a professor of economics and has raised more than $4.5 billion in ...

A bioadaptor implant adaptable to vessel physiology was linked to less target lesion failure and target vessel failure compared with a drug-eluting stent between 6 months and 2 years, researchers ...